glp 1 fgf21 agonist boehringer Safety and efficacy of GLP-1/FGF21 dual HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study Variant:10µg In-Vitro Research Injections of an ultra-long-acting

glp 1 fgf21 agonist boehringer Safety and efficacy of GLP-1/FGF21 dual HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study Variant:10µg In-Vitro Research Injections of an ultra-long-acting

Injections of an ultra-long-acting investigational GLP-1 agonist led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according to the ongoing VESPER

Its dosage is escalated every 4 weeks

In-Vitro Research

Variant:10µg

There’s no path through Medicare that avoids the Part B premium once you’re actually using the system